In vitro release of soluble CD23 by human lymphocytes in ragweed-sensitive versus nonatopic patients following stimulation with ragweed antigen E
- 1 April 1996
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 76 (4), 359-362
- https://doi.org/10.1016/s1081-1206(10)60038-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- CD23 expression on B‐lymphocytes and its modulation by cytokines in allergic patientsClinical and Experimental Allergy, 1993
- Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysisKidney International, 1993
- Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin‐4Arthritis & Rheumatism, 1993
- A new pair of surface molecules involved in human IgE regulationImmunology Today, 1993
- Expression, regulation and function of human FcεRII (CD23) antigenImmunologic Research, 1992
- In vitro synthesis of human IgE by neonatal lymphocytes: Enhancing effect of interferon-γCellular Immunology, 1990
- Human IgE-binding factorsImmunology Today, 1989
- Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide “dual pathway” of signallingEuropean Journal of Immunology, 1988
- Lymphocyte responses to ragweed antigens from different sourcesJournal of Allergy and Clinical Immunology, 1979
- Lymphocyte responses to purified ragweed allergens in vitro I. Proliferative responses in normal, newborn, agammaglobulinemic, and atopic subjectsJournal of Allergy and Clinical Immunology, 1977